Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

NCT00136903

Conditions
Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • St. Francis Hospital Indianapolis, Indiana, United States
  • Kansas City Cancer Centers - BMT Kansas City, Missouri, United States
  • The Cancer Center at Hackensack University Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

NCT00070018

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States
View all 48 locations
View Trial Details
Completed

Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)

NCT02038946

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Winship Cancer Institute. Atlanta, Georgia, United States
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
View all 45 locations
View Trial Details
Completed

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

NCT01988571

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
View all 51 locations
View Trial Details
Completed

A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)

NCT02857426

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City Of Hope Medical Center Duarte, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Inst, Inc Tampa, Florida, United States
View all 50 locations
View Trial Details
Completed

A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP

NCT02741388

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU Dijon Dijon, France
  • CHRU de Lille - Hôpital Claude Huriez Lille, France
  • CHU Montpellier - Hôpital Saint Eloi Montpellier, France
View Trial Details

Related conditions